Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP677711.RAsHdnRVkDGwzed4IQlL-g_Ceocfrp5B3gdbxwfN04eFE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP677711.RAsHdnRVkDGwzed4IQlL-g_Ceocfrp5B3gdbxwfN04eFE130_assertion type Assertion NP677711.RAsHdnRVkDGwzed4IQlL-g_Ceocfrp5B3gdbxwfN04eFE130_head.
- NP677711.RAsHdnRVkDGwzed4IQlL-g_Ceocfrp5B3gdbxwfN04eFE130_assertion description "[CYP2C19 genetic polymorphism also affects the therapeutic outcome of gastroesophageal reflux disease (GERD), reflux oesophagitis and duodenal ulcers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP677711.RAsHdnRVkDGwzed4IQlL-g_Ceocfrp5B3gdbxwfN04eFE130_provenance.
- NP677711.RAsHdnRVkDGwzed4IQlL-g_Ceocfrp5B3gdbxwfN04eFE130_assertion evidence source_evidence_literature NP677711.RAsHdnRVkDGwzed4IQlL-g_Ceocfrp5B3gdbxwfN04eFE130_provenance.
- NP677711.RAsHdnRVkDGwzed4IQlL-g_Ceocfrp5B3gdbxwfN04eFE130_assertion SIO_000772 18765869 NP677711.RAsHdnRVkDGwzed4IQlL-g_Ceocfrp5B3gdbxwfN04eFE130_provenance.
- NP677711.RAsHdnRVkDGwzed4IQlL-g_Ceocfrp5B3gdbxwfN04eFE130_assertion wasDerivedFrom befree-20140225 NP677711.RAsHdnRVkDGwzed4IQlL-g_Ceocfrp5B3gdbxwfN04eFE130_provenance.
- NP677711.RAsHdnRVkDGwzed4IQlL-g_Ceocfrp5B3gdbxwfN04eFE130_assertion wasGeneratedBy ECO_0000203 NP677711.RAsHdnRVkDGwzed4IQlL-g_Ceocfrp5B3gdbxwfN04eFE130_provenance.